Page last updated: 2024-12-08

n-(1-phenethylpiperidin-4-yl)-n-phenylacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide: a psychoactive street drug; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID527015
SCHEMBL ID684578
MeSH IDM000601886

Synonyms (30)

Synonym
acetanilide, n-(1-phenethyl-4-piperidyl)-
acetamide, n-phenyl-n-[1-(2-phenylethyl)-4-piperidinyl]-
n-(1-phenethylpiperidin-4-yl)-n-phenylacetamide
3258-84-2
n-(1-phenethyl-piperidin-4-yl)-n-phenyl-acetamide
acetyl fentanyl
fentanyl impurity c [ep]
acetamide, n-phenyl-n-(1-(2-phenylethyl)-4-piperidinyl)-
dea no. 9821
fentanyl specified impurity c [ep]
(n-(1-phenethylpiperidin-4-yl)-n-phenylacetamide)
n-phenyl-n-(1-(2-phenylethyl)piperidin-4-yl)acetamide
unii-6dz28538ks
piperidine, 1-phenethyl-4-(n-phenylacetamido)-
6dz28538ks ,
acetylfentanyl
fentanyl impurity c [ep impurity]
j125.906g ,
fentanyl citrate impurity c [ep impurity]
SCHEMBL684578
AM806987
FYIUUQUPOKIKNI-UHFFFAOYSA-N
n-phenyl-n-[1-(2-phenylethyl)-4-piperidinyl]acetamide #
AKOS025149437
DTXSID80186275
1-(2-phenylethyl)-4-(n-acetylphenylamino)piperidine
n-phenyl-n-[1-(2-phenylethyl)piperidin-4-yl]acetamide
AS-38221
Q15408427
acetyl fentanyl-13c6 (hydrochloride)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Acetylfentanyl can be managed effectively with naloxone, although higher than conventional dosing may be required to achieve therapeutic effect."( Acetylfentanyl: An Emerging Drug of Abuse.
Hoot, NR; Rehrer, SJ; Rogers, JS, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's19 (73.08)24.3611
2020's7 (26.92)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (10.71%)6.00%
Case Studies7 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (64.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]